![6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosylpurine-5′-monophosphate, Disodium Salt - chemical structure image](https://media.scbt.com/product/6-4-nitrobenzylthio-9-beta-d-ribofuranosylpurine-5prime-monophosphate-disodium-salt-structure_09_74_b_97433.jpg)
![Molekülstruktur von 6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosylpurine-5'-monophosphate, Disodium Salt 6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosylpurine-5′-monophosphate, Disodium Salt - chemical structure image](https://media.scbt.com/product/6-4-nitrobenzylthio-9-beta-d-ribofuranosylpurine-5prime-monophosphate-disodium-salt-structure_09_74_t_97433.jpg)
Direktverknüpfungen
Wird in der Therapie der Mausleukämie L1210 in Kombination mit Nebularin und Nitrobenzylthioinosin-5'-monophosphat verwendet.
Bestellinformation
| Produkt | Katalog # | EINHEIT | Preis | ANZAHL | Favoriten | |
6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosylpurine-5′-monophosphate, Disodium Salt, 5 mg | sc-223714 | 5 mg | $360.00 |